CMC Pharmaceuticals Competitors and Similar CompaniesClear all

CMC Pharmaceuticals's competitors and similar companies include FibroGen, CanSino Biologics, Worldwide Clinical Trials and Cayman Chemical.
CMC Pharmaceuticals
CMC Pharmaceuticals
CMC Pharmaceuticals is a company that provides drug product development solutions.
FibroGen
FibroGen
FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs.
CanSino Biologics
CanSino Biologics
CanSino Biologics (康希诺生物股份公司) is a biopharmaceutical company that provides solutions for the prevention and treatment of infectious diseases.
Worldwide Clinical Trials
Worldwide Clinical Trials
Worldwide Clinical Trials is a company that specializes in biotechnology and pharmaceutical research.
Cayman Chemical
Cayman Chemical
Cayman Chemical Company is a manufacturer and supplier of biochemicals, assay kits, antibodies, and recombinant proteins.
Founding Date
Founding Date
2014
Founding Date
1993
Founding Date
2009
Founding Date
1986
Founding Date
1980
Type
Type
Private
Type
Public
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
Solon, US HQ
Locations
San Francisco, US HQ
Locations
Tianjin, CN HQ
Locations
Durham, US HQ
Buenos Aires, AR
São Paulo, BR
Sofia, BG
Zagreb, HR
Prague, CZ
Paris, FR
see more
Locations
Ann Arbor, US HQ
Neratovice, CZ
Tallinn, EE
State College, US
Employees
Employees
148% increase
Employees
53115% increase
Employees
1,10526% decrease
Employees
3,5372% increase
Employees
2725% decrease

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$6.4m (FY, 2025)
Revenue (est.)
¥1.1b (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
$556k (FY, 2025)
Cost of goods
¥81.4m (FY, 2025)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$5.9m (FY, 2025)
Gross profit
¥1.1b (FY, 2025)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
N/A
Net income
$183.5m (FY, 2025)
Net income
¥27.9m (FY, 2025)
Net income
N/A
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 76m
Total funding raised
N/A
Total funding raised
$ 1.5m
For sources of this data, please see the company profile

View Company Profiles

FibroGen
HQ
San Francisco, US
Employees
531↑ 15% increase

FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs.

View company
CanSino Biologics
HQ
Tianjin, CN
Employees
1,105↓ 26% decrease

CanSino Biologics (康希诺生物股份公司) is a biopharmaceutical company that provides solutions for the prevention and treatment of infectious diseases.

View company
Worldwide Clinical Trials
HQ
Durham, US
Employees
3,537↑ 2% increase

Worldwide Clinical Trials is a company that specializes in biotechnology and pharmaceutical research.

View company
Cayman Chemical
HQ
Ann Arbor, US
Employees
272↓ 5% decrease

Cayman Chemical Company is a manufacturer and supplier of biochemicals, assay kits, antibodies, and recombinant proteins.

View company